INTERACTIVE PEER-TO-PEER DISCUSSIONS IN HEMATOLOGY/ONCOLOGY

1 total filings · 0 classes · Active since Jun 2008

INTERACTIVE PEER-TO-PEER DISCUSSIONS IN HEMATOLOGY/ONCOLOGY holds 1 USPTO trademark filings across 0 NICE classes. The largest concentration is in Class 41 (Education & Entertainment) with 1 filings. The WikiTrademarks Expansion Score is 0/100, low — the brand is focused on defending its existing categories rather than expanding.

USPTO data refreshed July 6, 2026

Own this brand? Claim the profile to add your logo, story, and website.

Sign in to claim

How is INTERACTIVE PEER-TO-PEER DISCUSSIONS IN HEMATOLOGY/ONCOLOGY filing trademarks, and where is the portfolio expanding?

Filing Velocity (24 Months)

Aug 2024 Jul 2026

Nice Class Distribution

Activity Timeline

No activity recorded yet.

Recent Filings

Serial No. Mark Filing Date Status Classes Owner
77496534 INTERACTIVE PEER-TO-PEER DISCUSSIONS IN HEMATOLOGY/ONCOLOGY Jun 11, 2008 Abandoned 041 Education & Entertainment THE LYNX GROUP, LLC
See how ChatGPT talks about INTERACTIVE PEER-TO-PEER DISCUSSIONS IN HEMATOLOGY/ONCOLOGY Beta

Weekly visibility reports showing how ChatGPT mentions INTERACTIVE PEER-TO-PEER DISCUSSIONS IN HEMATOLOGY/ONCOLOGY, where you rank in the answer, the sentiment of the mention, and which sources ChatGPT cites.

Join waitlist →

FAQ: INTERACTIVE PEER-TO-PEER DISCUSSIONS IN HEMATOLOGY/ONCOLOGY trademark portfolio

What trademarks does INTERACTIVE PEER-TO-PEER DISCUSSIONS IN HEMATOLOGY/ONCOLOGY hold?

INTERACTIVE PEER-TO-PEER DISCUSSIONS IN HEMATOLOGY/ONCOLOGY holds 1 USPTO trademark filings across 0 NICE classes. The largest concentration is in Class 41 (Education & Entertainment). The most recent filings are registered to THE LYNX GROUP, LLC.

How many trademarks does INTERACTIVE PEER-TO-PEER DISCUSSIONS IN HEMATOLOGY/ONCOLOGY have at the USPTO?

WikiTrademarks tracks 1 USPTO trademark filings attributed to INTERACTIVE PEER-TO-PEER DISCUSSIONS IN HEMATOLOGY/ONCOLOGY. The brand has been actively filing since June 2008. The count updates daily as new filings are indexed from the USPTO bulk data feed.

In which NICE classes does INTERACTIVE PEER-TO-PEER DISCUSSIONS IN HEMATOLOGY/ONCOLOGY file most often?

INTERACTIVE PEER-TO-PEER DISCUSSIONS IN HEMATOLOGY/ONCOLOGY's most active class is NICE Class 41 (Education & Entertainment), with 1 filings. The full distribution across all 0 classes is shown in the Nice Class Distribution panel on this page.

Who owns the INTERACTIVE PEER-TO-PEER DISCUSSIONS IN HEMATOLOGY/ONCOLOGY trademark?

The most recent filings under the INTERACTIVE PEER-TO-PEER DISCUSSIONS IN HEMATOLOGY/ONCOLOGY mark are registered to THE LYNX GROUP, LLC. Trademark ownership can shift through assignments — see the Ownership & Assignment History section on this page for the full chain of title.

Is INTERACTIVE PEER-TO-PEER DISCUSSIONS IN HEMATOLOGY/ONCOLOGY expanding into new categories?

The current WikiTrademarks Expansion Score for INTERACTIVE PEER-TO-PEER DISCUSSIONS IN HEMATOLOGY/ONCOLOGY is 0 out of 100, which is low — the brand is focused on defending its existing categories rather than expanding. The score combines NICE class breadth, filing velocity, and the rate of cross-class movement from the brand's filing history.

How can I track new INTERACTIVE PEER-TO-PEER DISCUSSIONS IN HEMATOLOGY/ONCOLOGY trademark filings?

Click the Watch Brand button at the top of this page to add INTERACTIVE PEER-TO-PEER DISCUSSIONS IN HEMATOLOGY/ONCOLOGY to your Watchlist. New filings show up on your WikiTrademarks dashboard within 24 to 48 hours of being public, alongside any class expansions, status changes, or assignment events.

More on this portfolio: Compare INTERACTIVE PEER-TO-PEER DISCUSSIONS IN HEMATOLOGY/ONCOLOGY to another owner · Browse all NICE classes · Most valuable brands

Community notes

0 notes
Sign in to add a note

Share what you know about INTERACTIVE PEER-TO-PEER DISCUSSIONS IN HEMATOLOGY/ONCOLOGY and help the next person researching it.

No notes yet. Be the first to add what you know about INTERACTIVE PEER-TO-PEER DISCUSSIONS IN HEMATOLOGY/ONCOLOGY.